Contrast Media Market By Type, Form, Modality, Route of Administration, Indication & Region - Global Forecast to 2031

1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered and Regions Considered
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Market Stakeholders
1.5 Summary of Changes

2.1 Market Highlights and Key Insights
2.2 Key Market Participants: Mapping of Strategic Developments
2.3 Disruptive Trends in Contrast Media Market
2.4 High Growth Segments

3.1 Contrast Media Market Overview
3.2 Contrast Media Market, by Region
3.3 Asia-Pacific: Contrast Media Market, by Country and End User
3.4 Geographic Snapshot of Contrast Media Market

4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Advancements in Contrast Agent Formulations
4.2.1.2 Precision Diagnostics Enabled by Targeted and Activatable Contrast Agents
4.2.1.3 Government Investments and Healthcare Procurement Initiatives
4.2.1.4 Rising Number of Contrast-Mediated Scans
4.2.2 Restraints
4.2.2.1 Limited Circulation Time and Stability of Certain Contrast Agents
4.2.2.2 Environmental Persistence of Gadolinium-Based Contrast Agents
4.2.3 Opportunities
4.2.3.1 Expansion of Multimodal Imaging Technologies
4.2.3.2 Expansion of Contrast-Enhanced Ultrasound (Ceus) Applications in Pediatric Imaging
4.2.3.3 Increasing Demand for Low-Dose, High-Relaxivity Contrast Agents for Neonates and Infants
4.2.4 Challenges
4.2.4.1 Safety and Toxicity Concerns Associated With Gadolinium and Nanoparticle-Based Contrast Agents
4.2.4.2 Complex Regulatory Approval Pathways for Novel and Multimodal Contrast Agents
4.2.4.3 Complexity in Scalable Synthesis and Standardization of Nanoparticle-Based Contrast Agents
4.3 Unmet Needs
4.4 Strategic Moves by Tier-1/2/3 Players

5.1 Porter’S Five Forces Analysis
5.2 Macroeconomic Indicators
5.2.1 Introduction
5.2.2 Healthcare Expenditure and Infrastructure Outlook
5.2.2.1 Macroeconomic Outlook for North America
5.2.3 Macroeconomic Outlook for Europe
5.2.4 Macroeconomic Outlook for Asia-Pacific
5.2.5 Macroeconomic Outlook for Latin America
5.2.6 Macroeconomic Outlook for Middle East & Africa
5.3 Supply Chain Analysis
5.4 Ecosystem Analysis
5.5 Pricing Analysis
5.5.1 Average Selling Price Trend, by Region
5.5.2 Average Selling Price of Contrast Media Products, by Key Player
5.5.3 Average Selling Price Trend of Contrast Media Products, by Key Player, 2024
5.6 Trade Data Analysis
5.6.1 Import Data (Hs Code 300630)
5.6.2 Export Data (Hs Code 300630)
5.7 Key Conferences & Events, 2026-2027
5.8 Trends/Disruptions Impacting Customer Business
5.9 Investment & Funding Scenario
5.10 Case Study Analysis
5.10.1 Case Study 1: Macrocyclic Contrast Agents for Improved Mri Safety
5.10.2 Case Study 2: Iodinated Contrast Media Optimization in Ct Imaging
5.10.3 Case Study 3: Low-Dose Mri Contrast Agent for Pediatric Mri Imaging
5.11 Impact of 2025 US Tariff- Contrast Media Market
5.11.1 Introduction
5.11.2 Key Tariff Rates
5.11.3 Price Impact Analysis
5.11.4 Impact on Country/Region
5.11.5 Impact on End Users

6.1 Buyer Stakeholders & Buying Evaluation Criteria
6.1.1 Buying Criteria
6.1.2 Decision-Making Process
6.2 Adoption Barriers & Internal Challenges
6.3 Unmet Needs From End Users
6.3.1 Unmet Needs From End Users

7.1 Key Technologies
7.1.1 Contrast-Enhanced Ultrasound (Ceus) Advancements
7.1.1.1 Targeted and Molecular Contrast Agents
7.1.1.2 Advanced Gadolinium-Based Agents and Hyperpolarized Techniques
7.1.2 Complementary Technologies
7.1.2.1 Automated Contrast Injector Systems
7.2 Patent Analysis
7.2.1 Contrast Media Market: List of Patents
7.3 Future Applications
7.4 Impact of AI/Gen AI on Contrast Media Market
7.4.1 Top Use Cases and Market Potential
7.4.2 Best Practices in Contrast Media.
7.4.3 Case Studies of AI Implementation in Contrast Media Market
7.4.4 Interconnected Adjacent Ecosystem and Impact on Market Players
7.4.5 Client Readiness to Adopt Generative AI in Contrast Media Market
7.5 Success Stories and Real-World Applications

8.1 Introduction
8.2 Iodinated Contrast Media
8.2.1 Rising Adoption of Ct Imaging Increases Demand
8.3 Gadolinium-Based Contrast Media
8.3.1 Safety Concerns Associated With Gadolinium-Based Contrast Agents Restrain Market Growth
8.4 Microbubble Contrast Media
8.4.1 Growing Physician Preference for Contrast-Enhanced Ultrasound Drives Adoption
8.5 Barium-Based Contrast Media
8.5.1 Adverse Effects Associated With Barium Sulfate Contrast Media Limit Clinical Usage

9.1 Introduction
9.2 Liquid
9.2.1 Convenience of Use in Hospitals and Diagnostic Centers to Drive Market Growth
9.3 Powder
9.3.1 Convenient Handling, Storage, and Transportation Drives Increased Adoption
9.4 Other Forms

10.1 Introduction
10.2 X-Ray
10.2.1 Development of Safer, Low-Concentration Contrast Agents for X-Ray - Key Opportunity
10.3 Ct
10.3.1 Increasing Number of Ct Examinations to Propel Market
10.4 Mri
10.4.1 Increasing Focus on Next-Generation Gadolinium-Based Contrast Agents to Enhance Safety and Imaging Performance
10.5 Ultrasound
10.5.1 Flexible and Low-Cost Diagnostic Imaging Modality - Key Factors Driving Market Growth

11.1 Introduction
11.2 Intravascular Route
11.2.1 Increasing Clinical Reliance for Enhanced Diagnostic Imaging and Treatment Outcomes to Drive Segment
11.2.1.1 Intravenous (Iv) Route
11.2.1.2 Intra-Arterial (Ia) Route
11.3 Oral Route
11.3.1 Enhancing Gastrointestinal Visualization With Oral Contrast Agents in Diagnostic Imaging
11.4 Rectal Route
11.4.1 Rising Demand for Accurate Post-Surgical Complication Detection to Drive Adoption
11.5 Other Routes

12.1 Introduction
12.2 Cardiovascular Disease
12.2.1 High Burden of Cvd to Drive Market
12.3 Cancer
12.3.1 Advanced Oncologic Diagnostics Through Contrast-Enhanced Ultrasound Imaging to Boost Segment
12.4 Gastrointestinal Disorders
12.4.1 Expanding Role of Ceus in Pediatric Gastrointestinal Disorders and Neonatal Imaging to Propel Growth
12.5 Musculoskeletal Disorders
12.5.1 Rising Incidence of Work-Related Musculoskeletal Disorders to Support Market Growth
12.6 Neurological Disorders
12.6.1 Increasing Burden of Neurological Disorders Drives Demand
12.7 Nephrological Disorders
12.7.1 Rising Prevalence of End-Stage Renal Disease to Drive Demand

13.1 Introduction
13.2 Radiology
13.2.1 Growing Number of Diagnostic Procedures to Drive Market
13.3 Interventional Radiology
13.3.1 Rising Adoption of Minimally Invasive Interventions to Drive Market
13.4 Interventional Cardiology
13.4.1 Rising Incidence of Cardiac Diseases to Drive Market

14.1 Introduction
14.2 Hospitals, Clinics, and Ambulatory Surgery Centers
14.2.1 Increasing Adoption of Diagnostic Imaging Modalities to Drive Market
14.3 Diagnostic Imaging Centers
14.3.1 Increasing Number of Private Imaging Centers to Propel Market

15.1 Introduction
15.2 North America
15.2.1 US
15.2.1.1 Rising Incidence of Chronic Diseases to Drive Market
15.2.2 Canada
15.2.2.1 Growth Influenced by Supply Expansion and Increasing Market Competition
15.3 Europe
15.3.1 Germany
15.3.1.1 Presence of Well-Established Players to Support Market Growth
15.3.2 France
15.3.2.1 Growth Supported by High Imaging Utilization and Expanding Clinical Applications
15.3.3 UK
15.3.3.1 Innovation in Next-Generation Mri Contrast Agents to Drive Growth
15.3.4 Italy
15.3.4.1 Growth Driven by Innovation in Ultrasound Contrast Agents and Product Expansion
15.3.5 Spain
15.3.5.1 Shift Toward Safer and Cost-Efficient Low-Osmolar Contrast Agents in Ct Imaging to Boost Market
15.3.6 Rest of Europe
15.4 Asia-Pacific
15.4.1 China
15.4.1.1 Strong Domestic Capabilities and Strategic Supply Chain Position Drive Market Growth
15.4.2 Japan
15.4.2.1 Advanced Imaging Infrastructure and Strategic Industry Expansion to Drive Demand
15.4.3 India
15.4.3.1 Expanding Domestic Manufacturing and Increasing Imaging Demand to Propel Market Growth
15.4.4 Australia
15.4.5 South Korea
15.4.5.1 AI-Driven Imaging Optimization and Rising Early-Onset Cancer Burden Reshaping Demand
15.4.6 Rest of Asia-Pacific
15.4.7 Latin America
15.4.7.1 Cost-Sensitive Procurement and Rising Ct Imaging Volumes Drive Contrast Media Utilization
15.4.8 Brazil
15.4.8.1 Rising Disease Burden Drives Demand Amid Safety and Access Challenges
15.4.9 Mexico
15.4.9.1 Rising Ckd Burden, Low Healthcare Spending, and Environmental Concerns Influence Contrast Media Utilization
15.4.10 Rest of Latin America
15.4.10.1 Fragmented Access, Import Dependence, and Public-Private Imbalance Shaping Contrast Media Utilization
15.4.11 Middle East & Africa
15.4.11.1 High Burden of Chronic Diseases to Drive Market
15.4.12 GCC Countries
15.4.12.1 Increasing Government Investments in Healthcare Sector and Growing Pharmaceuticals Industry to Drive Market
15.4.13 Rest of Middle East & Africa
15.4.13.1 Import Dependence and Unbalanced Imaging Access Driving Selective Contrast Media Utilization

16.1 Introduction
16.2 Key Players’ Strategies/Right to Win
16.2.1 Overview of Strategies Adopted by Key Players in Contrast Media Market
16.3 Revenue Analysis of Key Players in Contrast Media Market 2021-2025
16.4 Market Share Analysis, 2024
16.4.1 Market Ranking of Key Players, 2024
16.5 Company Valuation & Financial Metrics
16.5.1 Financial Metrics
16.5.2 Company Valuation
16.6 Brand/Product Comparison
16.7 Company Evaluation Matrix: Key Players, 2025
16.7.1 Stars
16.7.2 Pervasive Players
16.7.3 Emerging Leaders
16.7.4 Participants
16.7.5 Company Footprint: Key Players, 2025
16.7.5.1 Company Footprint
16.7.5.2 Region Footprint
16.7.5.3 Product Type Footprint
16.7.5.4 Modality Footprint
16.7.5.5 Route of Administration Footprint
16.7.5.6 Indication Footprint
16.7.5.7 End User Footprint
16.8 Company Evaluation Matrix: Startups/SMEs, 2025
16.8.1 Progressive Companies
16.8.2 Responsive Companies
16.8.3 Dynamic Companies
16.8.4 Starting Blocks
16.8.5 Competitive Benchmarking of Startups/SMEs, 2025
16.8.5.1 Contrast Media Market: Competitive Benchmarking of Startups/SMEs
16.9 Competitive Scenario
16.9.1 Product Launches & Approvals
16.9.2 Deals
16.9.3 Expansions

17.1 Key Players
17.1.1 Ge Healthcare
17.1.1.1 Business Overview
17.1.1.2 Products Offered
17.1.1.3 Recent Developments
17.1.1.3.1 Product Launches
17.1.1.4 The Analyst's View
17.1.1.4.1 Key Strengths
17.1.1.4.2 Strategic Choices
17.1.1.4.3 Weaknesses & Competitive Threats
17.1.2 Bracco Imaging
17.1.2.1 Business Overview
17.1.2.2 Products Offered
17.1.2.3 Recent Developments
17.1.2.3.1 Product Launches
17.1.2.3.2 Deals
17.1.2.4 The Analyst's View
17.1.2.4.1 Key Strengths
17.1.2.4.2 Strategic Choices
17.1.2.4.3 Weaknesses & Competitive Threats
17.1.3 Bayer AG
17.1.3.1 Business Overview
17.1.3.2 Products Offered
17.1.3.3 Recent Developments
17.1.3.3.1 Expansions
17.1.3.4 The Analyst's View
17.1.3.4.1 Key Strengths
17.1.3.4.2 Strategic Choices
17.1.3.4.3 Weaknesses & Competitive Threats
17.1.4 Guerbet
17.1.4.1 Business Overview
17.1.4.2 Products Offered
17.1.4.3 Recent Developments
17.1.4.3.1 Product Approvals
17.1.4.4 The Analyst's View
17.1.4.4.1 Key Strengths
17.1.4.4.2 Strategic Choices
17.1.4.4.3 Weaknesses & Competitive Threats
17.1.5 Lantheus Holdings, Inc.
17.1.5.1 Business Overview
17.1.5.2 Products Offered
17.1.5.3 The Analyst's View
17.1.5.3.1 Key Strengths
17.1.5.3.2 Strategic Choices
17.1.5.3.3 Weaknesses & Competitive Threats
17.1.6 Unijules Life Sciences Ltd.
17.1.6.1 Business Overview
17.1.6.2 Products Offered
17.1.7 J.B. Chemicals & Pharmaceuticals Limited
17.1.7.1 Business Overview
17.1.7.2 Products Offered
17.1.8 Sanochemia Pharmazeutika
17.1.8.1 Business Overview
17.1.8.2 Products Offered
17.1.9 Taejoon Pharm Co. Ltd.
17.1.9.1 Business Overview
17.1.9.2 Products Offered
17.1.10 Jodas Expoim
17.1.10.1 Business Overview
17.1.10.2 Products Offered
17.1.11 Imax Diagnostic Imaging Limited
17.1.11.1 Business Overview
17.1.11.2 Products Offered
17.1.11.3 Pipeline Products
17.1.12 Yangtze River Pharmaceutical Group
17.1.12.1 Business Overview
17.1.12.2 Pipeline Products
17.1.13 Livealth
17.1.13.1 Business Overview
17.1.13.2 Products Offered
17.1.14 Beijing Beilu Pharmaceutical Co. Ltd.
17.1.14.1 Business Overview
17.1.14.2 Products Offered
17.1.14.3 Recent Developments
17.2 Other Players
17.2.1 Arco Lifesciences (I) Pvt. Ltd.
17.2.2 Stanex Drugs & Chemicals Pvt. Ltd.
17.2.3 Onko Ilaç San. Ve Tic. A.S.
17.2.4 Fresenius Kabi
17.2.5 Biem Ilac San. Ve
17.2.6 Advacare Pharma
17.2.7 Fujifilm Wako Pure Chemical Corporation
17.2.8 Unispire Biopharma Private Limited
17.2.9 Trivitron Healthcare
17.2.10 Nanopet Pharma GmbH

18.1 Research Data
18.2 Research Design
18.2.1 Secondary Research
18.2.1.1 Objectives of Secondary Research
18.2.1.2 Key Data From Secondary Sources
18.2.2 Primary Research
18.2.2.1 Objectives of Primary Research
18.2.2.2 Key Industry Insights
18.3 Market Size Estimation Methodology
18.3.1 Bottom-Up Approach
18.3.1.1 Approach 1: Company Revenue Estimation Approach
18.3.1.2 Approach 4: Primary Interviews
18.3.2 Top-Down Approach
18.4 Market Breakdown and Data Triangulation
18.5 Market Share Assessment
18.6 Research Assumptions
18.7 Research Limitations
18.8 Risk Assessment

19.1 Discussion Guide
19.2 Knowledgestore: The Subscription Portal
19.3 Customization Options
19.4 Related Reports
19.5 Author Details

• Ge Healthcare
• Bracco Imaging
• Bayer AG
• Guerbet
• Lantheus Holdings, Inc.
• Unijules Life Sciences Ltd.
• J.B. Chemicals & Pharmaceuticals Limited
• Sanochemia Pharmazeutika
• Taejoon Pharm Co. Ltd.
• Jodas Expoim
• Imax Diagnostic Imaging Limited
• Yangtze River Pharmaceutical Group
• Livealth
• Beijing Beilu Pharmaceutical Co. Ltd.
• Arco Lifesciences (I) Pvt. Ltd.
• Stanex Drugs & Chemicals Pvt. Ltd.
• Onko Ilaç San. Ve Tic. A.S.
• Fresenius Kabi
• Biem Ilac San. Ve
• Advacare Pharma
• Fujifilm Wako Pure Chemical Corporation
• Unispire Biopharma Private Limited
• Trivitron Healthcare
• Nanopet Pharma GmbH

Table 1 Contrast Media Market: Inclusions and Exclusions
Table 2 Contrast Media Market: Impact Analysis of Market Dynamics
Table 3 Key Technological Advancements in Contrast Agent Formulations and Their Clinical Benefits
Table 4 Emerging Targeted and Activatable Contrast Agents Supporting Precision Diagnostics
Table 5 Emerging and Clinical Applications of Contrast-Enhanced Ultrasound (Ceus) in Pediatric Abdominal Imaging
Table 6 Contrast Agent Market: Unmet Needs
Table 7 Strategic Moves by Tier 1, Tier 2, and Tier 3 Players in Contrast Media Market
Table 8 Contrast Media Market: Porter’S Five Forces
Table 9 North America: Macroeconomic Outlook
Table 10 Europe: Macroeconomic Outlook
Table 11 Asia-Pacific: Macroeconomic Indicators
Table 12 Latin America: Macroeconomic Outlook
Table 13 Middle East & Africa: Macroeconomic Outlook
Table 14 Contrast Media Market: Role of Ecosystem
Table 15 Average Selling Price of Contrast Media Product Types, by Region, 2024-2026(USD)
Table 16 Average Selling Price Trend of Contrast Media Products, by Key Player, (USD)
Table 17 Import Data for Hs Code 300630, by Country, 2021-2025 (USD Thousand)
Table 18 Export Data for Hs Code 300630 by Country, 2021-2025 (USD Thousand)
Table 19 Contrast Media Market: Key Conferences & Events (2026-2027)
Table 20 Contrast Media Application in Mri Safety and Stability
Table 21 Contrast Media Application in Ct Imaging Optimization
Table 22 Contrast Media Application in Pediatric Mri Imaging
Table 23 US Adjusted Reciprocal Tariff Rates in Medtech Industry
Table 24 Influence of Stakeholders on Buying Process for Contrast Media Market, by Product
Table 25 Key Buying Criteria for Contrast Media Market, by End User
Table 26 Contrast Media Market: Unmet Need Analysis
Table 27 Key Agents Used in Contrast-Enhanced Ultrasound (Ceus)
Table 28 Contrast Media Market: Key Patents, 2016-2020
Table 29 Key Companies Implementing AI in Contrast Media Ecosystem
Table 30 Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 31 Iodinated Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 32 Gadolinium-Based Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 33 Microbubble Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 34 Barium-Based Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 35 Contrast Media Market, by Form, 2024-2031 (USD Million)
Table 36 Liquid Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 37 Powder Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 38 Other Forms: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 39 Contrast Media Market, by Modality, 2024-2031 (USD Million)
Table 40 England: Count of X-Ray Imaging Activity on Nhs Patients, May 2023-May 2024
Table 41 X-Ray: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 42 England: Count of Ct Imaging Activity on Nhs Patients, May 2023-May 2024
Table 43 Ct: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 44 England: Count of Mri Imaging Activity on Nhs Patients, May 2023-May 2024
Table 45 Mri: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 46 England: Count of Ultrasound Imaging Activity on Nhs Patients, May 2023-May 2024
Table 47 Ultrasound: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 48 Contrast Media Market, by Route of Administration, 2024-2031 (USD Million)
Table 49 Intravascular Route: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 50 Iv Route: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 51 Ia Route: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 52 Types of Oral Ct Contrast Agents, Including Agents Currently Available and Agents Under Development
Table 53 Oral Route: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 54 Rectal Route: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 55 Other Routes: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 56 Contrast Media Market, by Indication, 2024-2031 (USD Million)
Table 57 Cardiovascular Disease: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 58 Cancer: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 59 Gastrointestinal Disorders: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 60 Musculoskeletal Disorders: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 61 Neurological Disorders: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 62 Nephrological Disorders: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 63 Contrast Media Market, by Application, 2024-2031 (USD Million)
Table 64 Radiology: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 65 Interventional Radiology: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 66 Interventional Cardiology: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 67 Contrast Media Market, by End User, 2024-2031 (USD Million)
Table 68 Hospitals, Clinics, and Ambulatory Surgery Centers: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 69 Diagnostic Imaging Centers: Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 70 Contrast Media Market, by Region, 2024-2031 (USD Million)
Table 71 North America: Contrast Media Market, by Country, 2024-2031 (USD Million)
Table 72 North America: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 73 North America: Contrast Media Market, by Form, 2024-2031 (USD Million)
Table 74 North America: Contrast Media Market, by Modality, 2024-2031 (USD Million)
Table 75 North America: Contrast Media Market, by Route of Administration, 2024-2031 (USD Million)
Table 76 North America: Contrast Media Market, by Intravascular Route, 2024-2031 (USD Million)
Table 77 North America: Contrast Media Market, by Indication, 2024-2031 (USD Million)
Table 78 North America: Contrast Media Market, by Application, 2024-2031 (USD Million)
Table 79 North America: Contrast Media Market, by End User, 2024-2031 (USD Million)
Table 80 US: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 81 Canada: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 82 Europe: Contrast Media Market, by Country, 2024-2031 (USD Million)
Table 83 Europe: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 84 Europe: Contrast Media Market, by Form, 2024-2031 (USD Million)
Table 85 Europe: Contrast Media Market, by Modality, 2024-2031 (USD Million)
Table 86 Europe: Contrast Media Market, by Route of Administration, 2024-2031 (USD Million)
Table 87 Europe: Contrast Media Market, by Intravascular Route, 2024-2031 (USD Million)
Table 88 Europe: Contrast Media Market, by Indication, 2024-2031 (USD Million)
Table 89 Europe: Contrast Media Market, by Application, 2024-2031 (USD Million)
Table 90 Europe: Contrast Media Market, by End User, 2024-2031 (USD Million)
Table 91 Germany: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 92 France: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 93 UK: Count of Imaging Activity on Nhs Patients, May 2023-May 2024
Table 94 UK: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 95 Italy: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 96 Spain: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 97 Rest of Europe: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 98 Asia-Pacific: Contrast Media Market, by Country, 2024-2031 (USD Million)
Table 99 Asia-Pacific: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 100 Asia-Pacific: Contrast Media Market, by Form, 2024-2031 (USD Million)
Table 101 Asia-Pacific: Contrast Media Market, by Modality, 2024-2031 (USD Million)
Table 102 Asia-Pacific: Contrast Media Market, by Route of Administration, 2024-2031 (USD Million)
Table 103 Asia-Pacific: Contrast Media Market, by Intravascular Route, 2024-2031 (USD Million)
Table 104 Asia-Pacific: Contrast Media Market, by Application, 2024-2031 (USD Million)
Table 105 Asia-Pacific: Contrast Media Market, by Indication, 2024-2031 (USD Million)
Table 106 Asia-Pacific: Contrast Media Market, by End User, 2024-2031 (USD Million)
Table 107 China: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 108 Japan: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 109 India: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 110 High Cancer Burden and Strong Healthcare Spending - Key Demand Drivers
Table 111 Australia: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 112 South Korea: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 113 Rest of Asia-Pacific: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 114 Latin America: Contrast Media Market, by Country, 2024-2031 (USD Million)
Table 115 Latin America: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 116 Latin America: Contrast Media Market, by Form, 2024-2031 (USD Million)
Table 117 Latin America: Contrast Media Market, by Modality, 2024-2031 (USD Million)
Table 118 Latin America: Contrast Media Market, by Route of Administration, 2024-2031 (USD Million)
Table 119 Latin America: Contrast Media Market, by Intravascular Route, 2024-2031 (USD Million)
Table 120 Latin America: Contrast Media Market, by Application, 2024-2031 (USD Million)
Table 121 Latin America: Contrast Media Market, by Indication, 2024-2031 (USD Million)
Table 122 Latin America: Contrast Media Market, by End User, 2024-2031 (USD Million)
Table 123 Brazil: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 124 Mexico: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 125 Rest of Latin America: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 126 Middle East & Africa: Contrast Media Market, by Country, 2024-2031 (USD Million)
Table 127 Middle East & Africa: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 128 Middle East & Africa: Contrast Media Market, by Form, 2024-2031 (USD Million)
Table 129 Middle East & Africa: Contrast Media Market, by Modality, 2024-2031 (USD Million)
Table 130 Middle East & Africa: Contrast Media Market, by Route of Administration, 2024-2031 (USD Million)
Table 131 Middle East & Africa: Contrast Media Market, by Intravascular Route, 2024-2031 (USD Million)
Table 132 Middle East & Africa: Contrast Media Market, by Application, 2024-2031 (USD Million)
Table 133 Middle East & Africa: Contrast Media Market, by Indication, 2024-2031 (USD Million)
Table 134 Middle East & Africa: Contrast Media Market, by End User, 2024-2031 (USD Million)
Table 135 GCC Countries: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 136 Rest of Middle East & Africa: Contrast Media Market, by Type, 2024-2031 (USD Million)
Table 137 Overview of Strategies Deployed by Key Players in Contrast Media Market, 2022-2025
Table 138 Contrast Media Market: Degree of Competition
Table 139 Contrast Media Market: Region Footprint
Table 140 Contrast Media Market: Product Type Footprint
Table 141 Contrast Media Market: Modality Footprint
Table 142 Contrast Media Market: Route of Administration Footprint
Table 143 Contrast Media Market: Indication Footprint
Table 144 Contrast Media Market: End User Footprint
Table 145 Contrast Media Market: Competitive Benchmarking of Key Startups/ SME Players, by Product Type, and Region
Table 146 Contrast Media Market: Product Launches & Approvals, January 2023-June 2026
Table 147 Contrast Media Market: Deals, January 2023-June 2026
Table 148 Contrast Media Market: Expansions, January 2023-June 2026
Table 149 Ge Healthcare: Company Overview
Table 150 Ge Healthcare: Products Offered
Table 151 Ge Healthcare: Product Launches, January 2023-January 2026
Table 152 Bracco Imaging: Company Overview
Table 153 Bracco Imaging: Products Offered
Table 154 Bracco Imaging: Product Launches, January 2023-January 2026
Table 155 Bracco Imaging: Deals, January 2023-January 2026
Table 156 Bayer AG: Company Overview
Table 157 Bayer AG: Products Offered
Table 158 Bayer AG: Expansions, January 2023-January 2026
Table 159 Guerbet : Company Overview
Table 160 Guerbet: Products Offered
Table 161 Guerbet : Product Approvals, January 2023-January 2026
Table 162 Lantheus Holdings, Inc.: Company Overview
Table 163 Lantheus Holdings, Inc.: Products Offered
Table 164 Unijules Life Sciences Ltd.: Company Overview
Table 165 Unijules Life Sciences Ltd. Products Offered
Table 166 J.B. Chemicals & Pharmaceuticals Limited: Company Overview
Table 167 J.B. Chemicals & Pharmaceuticals Limited: Products Offered
Table 168 Sanochemia Pharmazeutika: Business Overview
Table 169 Sanochemia Pharmazeutika GmbH : Products Offered
Table 170 Taejoon Pharm Co. Ltd.: Business Overview
Table 171 Taejoon Pharm Co. Ltd.: Products Offered
Table 172 Jodas Expoim: Business Overview
Table 173 Jodas Expoim : Products Offered
Table 174 Imax Diagnostic Imaging Limited: Business Overview
Table 175 Imax Diagnostic Imaging Limited : Products Offered
Table 176 Imax Diagnostic Imaging Limited : Pipeline Products
Table 177 Yangtze River Pharmaceutical Group: Business Overview
Table 178 Yangtze River Pharmaceutical Group: Pipeline Products
Table 179 Livealth: Business Overview
Table 180 Livealth: Products Offered
Table 181 Beijing Beilu Pharmaceutical Co. Ltd.: Business Overview
Table 182 Beijing Beilu Pharmaceutical Co. Ltd.: Products Offered
Table 183 Beijing Beilu Pharmaceutical Co. Ltd.: Other Developments, January 2023-January 2026
Table 184 Arco Lifesciences (I) Pvt. Ltd.: Company Overview
Table 185 Stanex Drugs & Chemicals Pvt. Ltd.: Company Overview
Table 186 Onko Ilac San. Ve Tic. A.S.: Company Overview
Table 187 Fresenius Kabi: Company Overview
Table 188 Biem Ilac San. Ve: Company Overview
Table 189 Advacare Pharma: Company Overview
Table 190 Fujifilm Wako Chemical Corporation: Company Overview
Table 191 Trivitron Healthcare: Company Overview
Table 192 Nanopet Pharma GmbH: Company Overview
Table 193 Contrast Media Market: Research Assumptions

Figure 1 Contrast Media Market Segmentation and Regional Scope
Figure 2 Market Scenario
Figure 3 Global Contrast Media Market, 2023-2031
Figure 4 Major Strategies Adopted by Key Players in Contrast Media Market, 2020-2025
Figure 5 Disruptions Influencing Growth of Contrast Media Market
Figure 6 High-Growth Segments in Contrast Media Market, 2025-2031
Figure 7 Asia-Pacific to Register Highest Cagr in Contrast Media Market During Forecast Period
Figure 8 Contrast Media Market Driven by Rising Imaging Volumes, Low-Dose Innovations, and Expanding Adoption Across Key Regions
Figure 9 North America to Command Largest Market Share
Figure 10 Hospitals, Clinics, and Ambulatory Surgery Centers Accounted for Largest Market Share in 2024
Figure 11 China to Register Highest Growth Rate From 2025 to 2031
Figure 12 Contrast Agent Market: Drivers, Restraints, Opportunities, and Challenges
Figure 13 Contrast Media Market: Porter’S Five Forces Analysis
Figure 14 Contrast Media Market: Supply Chain Analysis
Figure 15 Contrast Media Market: Ecosystem Analysis
Figure 16 Average Selling Price Trend of Contrast Media Products, by Region, 2026-2024 (USD)
Figure 17 Average Selling Price of Contrast Media Products, by Key Player
Figure 18 Contrast Media Market: Trends/Disruptions Impacting Customer Business
Figure 19 Contrast Media Market: Funding Scenario, 2019-2023 (USD Million)
Figure 20 Number of Deals in Contrast Media Market, by Key Player, 2019-2023
Figure 21 Value of Deals in Contrast Media Market, by Key Player, 2019-2023 (USD)
Figure 22 Influence of Key Stakeholders on Buying Process for Contrast Media Market, by Product
Figure 23 Key Buying Criteria for End Users
Figure 24 Contrast Media Market: Unmet Need Analysis
Figure 25 Patent Analysis for Contrast Media Market, January 2015-December 2025
Figure 26 Key AI Use Cases in Contrast Media Ecosystem
Figure 27 North America: Contrast Media Market Snapshot
Figure 28 Asia-Pacific: Contrast Media Market Snapshot
Figure 29 Revenue Analysis of Key Players in Contrast Media Market, 2021-2025 (USD Million)
Figure 30 Contrast Media Market Share Analysis of Key Players, 2024
Figure 31 Ranking of Key Players in Contrast Media Market (2024)
Figure 32 Ev/EBITDA of Top Players (2026)
Figure 33 Year-to-Date (YTD) Price Total Return and 5-Year Stock Beta of Top Players (2026)
Figure 34 Contrast Media Market: Brand/Product Comparative Analysis
Figure 35 Contrast Media Market: Company Evaluation Matrix (Key Players), 2025
Figure 36 Contrast Media Market: Company Footprint
Figure 37 Contrast Media Market: Company Evaluation Matrix (Startups/SMEs), 2025
Figure 38 Ge Healthcare: Company Snapshot (2025)
Figure 39 Bayer AG: Company Snapshot (2025)
Figure 40 Guerbet: Company Snapshot (2025)
Figure 41 Lantheus Holdings, Inc.: Company Snapshot (2025)
Figure 42 J.B. Chemicals & Pharmaceuticals Limited: Company Snapshot (2025)
Figure 43 Contrast Media Market: Research Data
Figure 44 Contrast Media Market: Research Design
Figure 45 Primary Sources
Figure 46 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 47 Breakdown of Primary Interviews: Supply-Side and Demand-Side Participants
Figure 48 Research Methodology: Hypothesis Building
Figure 49 Contrast Media Market Size Estimation: Approach 1 (Company Revenue Estimation)
Figure 50 Market Size Estimation: Top-Down Approach
Figure 51 Data Triangulation